Pediatric PH Patients
Pediatric Clinical Care
The Vera Moulton Wall Center for Pulmonary Vascular Disease at Stanford is one of the nation’s leading centers for the research, diagnosis and treatment of pulmonary vascular disease in children. Whether newborn or adolescent, our expert team works closely with your family to develop the best treatment plan specific to your child’s symptoms and needs. Out team of expert physicians, nurse practitioners, and social workers is with your family every step of the way; working to ensure your child receives the best care possible in a supportive and nurturing environment.
Meet the Pediatric PH Team
Julian Cameron, MD
Pediatric Cardiology Fellow
Tamzen Hull, MSW
Pediatric PH Social Worker
Rebecca Kameny, MD
Clinical Assistant Professor
Division of Pediatric Cardiology
For new and return pediatric PH patient appointments please contact:
Consultations and Referrals
Stanford Children’s Health partners with referring physicians to ensure the best possible care for patients who need specialized health services. We are happy to discuss patients with referring physicians seeking information on the phone 1-800-640-WALL (9255) or via email (email@example.com). If the decision is made to refer the patient to Stanford for an in-person consultation, the child will be seen at the Children’s Heart Center at Lucile Packard Children’s Hospital Stanford.
For outpatient patient referrals, contact our Referral Center: (800) 995-5724. Please specify that you would like to refer a patient to the Pulmonary Hypertension clinic under the Direction of Dr. Jeffrey Feinstein.
For inpatient consultations and transfers, contact our Transfer Center: (650) 723-7342. If necessary, you can also ask to speak to the pediatric cardiologist on-call.
About the Center
The Wall Center seeks to enhance the lives of patients with pulmonary vascular disease by providing the highest level of clinical care, providing advanced training opportunities for physicians and other health care providers, and participating in clinical and bench-top research in pulmonary vascular disease.